Acelyrin Inc.

09/25/2024 | Press release | Archived content

Efficacy and Safety of Izokibep, a Novel IL 17A Inhibitor, in Moderate to Severe Hidradenitis Suppurativa: Week 12 Results from a Randomized, Double Blind, Placebo Controlled,[...]